Brainstorm announces full year 2020 financial results and provides a corporate update

New york, feb. 4, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the fiscal year ended december 31, 2020, and provided a corporate update. "in 2020 we...
BCLI Ratings Summary
BCLI Quant Ranking